Extended interval BNT162b2 vaccination enhances peak antibody generation. (2022)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-022-00432-w
PubMed Identifier: 35087066
Publication URI: http://europepmc.org/abstract/MED/35087066
Type: Journal Article/Review
Volume: 7
Parent Publication: NPJ vaccines
Issue: 1
ISSN: 2059-0105